Unicycive Therapeutics (UNCY) Stock Chart & Stock Price History → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free UNCY Stock Alerts $1.04 +0.01 (+0.97%) (As of 05/17/2024 08:54 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Unicycive Therapeutics Stock Price Performance5 Day Performance-3.70%1 Month Performance-2.80%3 Month Performance-28.77%6 Month Performance+100.00%Year-To-Date Performance+19.86%1 Year Performance-24.64% Receive UNCY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Unicycive Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaThe Overlooked Retirement Asset You Probably Don’t Own4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now. UNCY Stock Chart for Monday, May, 20, 2024 UNCY Chart by TradingView Unicycive Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$1.03$1.04+0.97%$1.06$1.01220,288 shs$39.11 million05/16/2024$1.08$1.03-4.63%$1.08$1.03228,022 shs$38.74 million05/15/2024$1.09$1.08-0.92%$1.11$1.0871,647 shs$40.62 million05/14/2024$1.09$1.09$1.16$1.06147,427 shs$41.00 million05/13/2024$1.13$1.09-3.54%$1.14$1.0856,992 shs$41.00 million05/10/2024$1.08$1.13+4.63%$1.14$1.05278,502 shs$42.50 million Get the Latest News and Ratings for UNCY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Unicycive Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/09/2024$1.13$1.08-4.42%$1.14$1.01372,275 shs$40.62 million05/08/2024$1.16$1.13-2.59%$1.15$1.1170,275 shs$42.50 million05/07/2024$1.18$1.16-1.69%$1.20$1.14149,758 shs$43.63 million05/06/2024$1.12$1.18+5.36%$1.21$1.10363,816 shs$44.38 million05/03/2024$1.12$1.12$1.15$1.11168,641 shs$42.12 million05/02/2024$1.14$1.12-1.32%$1.17$1.10238,990 shs$42.12 million05/01/2024$1.12$1.14+1.34%$1.16$1.11273,982 shs$42.12 million04/30/2024$1.22$1.12-8.20%$1.25$1.09523,099 shs$38.93 million04/29/2024$1.03$1.22+18.45%$1.29$1.011.99 million shs$42.41 million04/26/2024$0.97$1.03+6.19%$1.03$0.95232,305 shs$35.80 million04/25/2024$1.04$0.97-6.73%$1.05$0.93498,047 shs$33.72 million04/24/2024$1.07$1.04-2.80%$1.09$1.04179,329 shs$36.15 million04/23/2024$1.15$1.07-6.96%$1.19$1.07243,117 shs$37.19 million04/22/2024$1.07$1.15+7.48%$1.20$1.05458,697 shs$39.97 million04/19/2024$1.09$1.07-1.83%$1.13$1.04226,754 shs$37.19 million04/18/2024$1.16$1.09-5.63%$1.18$1.05893,190 shs$37.89 million04/17/2024$1.13$1.16+2.67%$1.16$1.12137,251 shs$40.15 million04/16/2024$1.14$1.13-1.32%$1.14$1.02535,343 shs$39.11 million04/15/2024$1.22$1.14-6.56%$1.24$1.101.07 million shs$39.63 million04/12/2024$1.25$1.22-2.40%$1.28$1.17410,594 shs$42.41 million04/11/2024$1.30$1.25-3.85%$1.35$1.25121,640 shs$43.45 million04/10/2024$1.32$1.30-1.52%$1.32$1.26168,586 shs$45.19 million04/09/2024$1.39$1.32-4.69%$1.39$1.29236,069 shs$45.88 million04/08/2024$1.42$1.39-2.46%$1.45$1.36204,243 shs$48.14 million04/05/2024$1.46$1.42-2.74%$1.49$1.37233,816 shs$49.36 million04/04/2024$1.37$1.46+6.57%$1.60$1.421.06 million shs$50.74 million04/03/2024$1.38$1.37-0.72%$1.40$1.33111,536 shs$47.62 million04/02/2024$1.41$1.38-2.13%$1.43$1.37980,019 shs$47.96 million04/01/2024$1.38$1.41+2.17%$1.52$1.36162,167 shs$49.00 million03/29/2024$1.38$1.38$1.48$1.38171,779 shs$47.96 million03/28/2024$1.46$1.38-5.48%$1.48$1.38171,379 shs$47.96 million03/27/2024$1.45$1.46+0.69%$1.47$1.4379,435 shs$50.74 million03/26/2024$1.52$1.45-4.61%$1.56$1.42221,173 shs$50.39 million03/25/2024$1.47$1.52+3.40%$1.60$1.45334,604 shs$52.82 millionThe Overlooked Retirement Asset You Probably Don’t Own (Ad)4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now.03/22/2024$1.33$1.47+10.53%$1.48$1.32359,330 shs$51.08 million03/21/2024$1.42$1.33-6.34%$1.43$1.32161,222 shs$46.22 million03/20/2024$1.39$1.42+2.16%$1.45$1.39293,298 shs$49.35 million03/19/2024$1.43$1.39-2.80%$1.47$1.39266,297 shs$48.31 million03/18/2024$1.46$1.43-2.05%$1.51$1.42201,723 shs$49.69 million03/15/2024$1.44$1.46+1.39%$1.52$1.41364,342 shs$50.74 million03/14/2024$1.39$1.44+3.60%$1.73$1.441.71 million shs$50.05 million03/13/2024$1.43$1.39-2.80%$1.47$1.38152,843 shs$48.30 million03/12/2024$1.49$1.43-4.03%$1.51$1.33273,049 shs$49.69 million03/11/2024$1.52$1.49-1.97%$1.55$1.47117,116 shs$51.78 million03/08/2024$1.50$1.52+1.33%$1.55$1.39392,538 shs$52.82 million03/07/2024$1.53$1.50-1.96%$1.56$1.48721,864 shs$52.13 million03/06/2024$1.47$1.53+4.08%$1.56$1.44196,341 shs$53.17 million03/05/2024$1.49$1.47-1.34%$1.55$1.40140,485 shs$51.09 million03/04/2024$1.60$1.49-6.88%$1.66$1.47390,538 shs$51.78 million03/01/2024$1.38$1.60+15.94%$1.63$1.39519,390 shs$55.60 million02/29/2024$1.41$1.38-2.13%$1.41$1.38232,250 shs$47.96 million02/28/2024$1.50$1.41-6.00%$1.51$1.25684,483 shs$49.00 million02/27/2024$1.58$1.50-5.06%$1.60$1.48223,424 shs$52.13 million02/26/2024$1.79$1.58-11.73%$1.80$1.211.24 million shs$54.91 million02/23/2024$1.75$1.79+2.29%$1.80$1.61348,608 shs$62.20 million02/22/2024$1.64$1.75+6.71%$1.82$1.51759,216 shs$60.81 million02/21/2024$1.46$1.64+12.33%$1.65$1.38509,052 shs$56.99 million02/20/2024$1.37$1.46+6.57%$1.52$1.30641,701 shs$50.74 million02/19/2024$1.37$1.37$1.44$1.26419,000 shs$47.61 million Related Companies: Xilio Therapeutics Stock Price Chart VYNE Therapeutics Stock Price Chart CASI Pharmaceuticals Stock Price Chart Eyenovia Stock Price Chart Gain Therapeutics Stock Price Chart Lexaria Bioscience Stock Price Chart Cara Therapeutics Stock Price Chart HCW Biologics Stock Price Chart Ocuphire Pharma Stock Price Chart Sensei Biotherapeutics Stock Price Chart Receive UNCY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Unicycive Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:UNCY) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDoes this make you sick?Allegiance GoldUrgent Nvidia WarningAltimetryThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarShocking: One AI startup's revenue could surge 4,735%Manward PressGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Unicycive Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.